- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-149/08: Order of the General Court of 13 September 2010 — Abbott Laboratories v OHIM — aRigen (Sorvir) (Community trade mark — Opposition proceedings — Application for Community word mark Sorvir — Earlier Community word mark NORVIR — Relative ground for refusal — Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))
ECLI:EU:UNKNOWN:62008TB0149
62008TB0149
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
6.11.2010
Official Journal of the European Union
C 301/26
(Case T-149/08) (<a id="ntc1-C_2010301EN.01002603-E0001" href="#ntr1-C_2010301EN.01002603-E0001"> (<span class="super">1</span>)</a>)
(Community trade mark - Opposition proceedings - Application for Community word mark Sorvir - Earlier Community word mark NORVIR - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))
2010/C 301/43
Language of the case: English
Parties
Applicant: Abbott Laboratories (Abbott Park, Illinois, United States) (represented by: S. Schäffler, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: J. Crespo Carrillo and A. Folliard-Monguiral, Agents)
Other party to the proceedings before the Board of Appeal of OHIM: aRigen, Inc. (Tokyo, Japan)
Re:
Action brought against the decision of the Second Board of Appeal of OHIM of 6 February 2008 (Case R 809/2007-2) relating to opposition proceedings between Abbott Laboratories and aRigen, Inc.
Operative part of the order
The General Court:
1.Annuls the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 6 February 2008 (Case R 809/2007-2);
2.Orders OHIM to bear its own costs and to pay those of Abbott Laboratories.
(<a id="ntr1-C_2010301EN.01002603-E0001" href="#ntc1-C_2010301EN.01002603-E0001">(<span class="super">1</span>)</a> OJ C 142, 7.6.2008).